Back to headlines

img

Pfizer vaccine data meets expectations for emergency use approval: US FDA

Pfizer cleared the next hurdle in the race to get its COVID-19 vaccine approved for emergency use in the United States on Tuesday after the US Food and Drug Administration (FDA) released documents that raised no new issues about its safety or efficacy. Pfizer and German partner BioNTech submitted data to the FDA last month about their coronavirus vaccine based on data showing the two-dose regimen was 95 percent effective against COVID-19 and had no major safety issues.

News source ~ Aljazeera